Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity (ROP1)
Research Grant
Administered By
Ophthalmology
Awarded By
Jaeb Center For Health Research
Start Date
January 1, 2015
End Date
January 31, 2022
Administered By
Ophthalmology
Awarded By
Jaeb Center For Health Research
Start Date
January 1, 2015
End Date
January 31, 2022